Trial intelligence / Profile preview

Therapeutic effect of saffron extract in patients with chronic schizophrenia

IRCT20210525051404N1Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of saffron extract in schizophrenia, sponsored by Kerman University of Medical Sciences. Started Aug 2021; status: completed.

02

Drugs

saffron extract
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT20210525051404N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210525051404N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call